查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1612275

心房颤动手术市场：按产品、适应症和最终用户 - 2025-2030 年全球预测

Atrial Fibrillation Surgery Market by Product (Cardiac Cryoablation Catheters, Cardiac Mapping System), Indication (Atrial Fibrillation (AFib), Atrial Flutter, Supraventricular Tachycardia (SVT)), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，心房颤动手术市场价值为26.7亿美元，预计到2024年将达到29亿美元，复合年增长率为9.00%，到2030年将达到48.8亿美元。

心房颤动 (AF) 手术是一种纠正与心房颤动相关的不规则心率的医疗程序，通常在微创治疗失败时进行。这些手术，如心导管电气烧灼术和迷宫手术，至关重要，因为心房颤动可导致中风和心臟衰竭等严重併发症。其涵盖范围涵盖有症状的患者和高併发症风险的患者，并得到医院和心臟专科中心的协助。全球心房颤动手术市场主要受到人口老化以及患者和医疗保健提供者意识不断提高导致心房颤动盛行率不断增加的影响。机器人辅助手术和改进的导管设计等创新有可能改善结果并缩短恢復时间。然而，这些程序的高昂成本以及欠发达地区的准入限制阻碍了市场的扩张。监管环境和对熟练专业人员的需求使情况更加复杂。技术共用和培训方面的策略伙伴关係和合作可能是克服这些障碍的关键。在研究和创新方面，人工智慧诊断工具、手术规划工具和改进的术后监测系统等领域提供了一个有希望的成长途径。此外，更强大的保险覆盖范围和报销框架可以加速市场开拓。该市场的特点是技术快速进步，但也面临监管审查，凸显了合规性和强大的临床检验的必要性。为了获得市场占有率，公司必须专注于价值提案，包括具有成本效益的解决方案和改善的患者治疗结果。总体而言，研发方面的策略性投资以及扩大患者就诊范围和简化手术成本的努力对于心房颤动手术市场的持续成长至关重要。

主要市场统计
基准年[2023] 26.7亿美元
预测年份 [2024] 29亿美元
预测年份 [2030] 48.8亿美元
复合年增长率（%） 9.00%

市场动态：快速发展的心房颤动手术市场的关键市场洞察

心房颤动手术市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 老年族群中心心房颤动的盛行率上升
    • 心律不整治疗中心导管电气烧灼术偏好的发展
    • 增加心房颤动计画以提高公众意识
  • 市场限制因素
    • 与设备相关的监管问题
  • 市场机会
    • 对微创手术、较小的心臟切口和更快的术后恢復时间的需求不断增加
    • 心房颤动心导管电气烧灼术技术进展
  • 市场挑战
    • 缺乏熟练的专业人员和人们对手术的看法

波特五力：驾驭心房颤动手术市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解心房颤动手术市场的外部影响

外部宏观环境因素在塑造心房颤动手术市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解心房颤动手术市场的竞争格局

对心房颤动手术市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵心房颤动手术市场供应商的绩效评估

FPNV定位矩阵是评估心房颤动手术市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了心房颤动手术市场的成功之路

对于想要加强在全球市场的影响力的公司来说，对心房颤动手术市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 老年人心房颤动盛行率上升
      • 优先发展心导管电气烧灼术治疗心律不整
      • 增加 AF 项目以提高公众意识
    • 抑制因素
      • 与设备相关的监管问题
    • 机会
      • 对微创手术、较小的心臟切口和更短的术后恢復时间的需求日益增长。
      • 心房颤动心导管电气烧灼术消融技术进展
    • 任务
      • 缺乏熟练的专业人员和公众缺乏手术意识
  • 市场区隔分析
    • 产品：随着基于导管的手术的使用越来越多，对微创手术的需求也在增加。
    • 适应症：迷路手术作为心房颤动的首选治疗方法的出现
    • 最终用户：加速心臟病学和多专科中心进行的心房颤动手术
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章心房颤动手术市场：副产品

  • 心臟冷冻消融导管
  • 心臟定位系统

第七章 心房颤动手术市场（按适应症）

  • 心房颤动 (AFib)
  • 心房扑动
  • 心室上性心搏过速 (SVT)

第八章心房颤动手术市场：依最终用户分类

  • 心臟病学
  • 多专业

第九章北美和南美心房颤动手术市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区心房颤动手术市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的心房颤动手术市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • GE 医疗保健推出用于治疗心房颤动的 CardioVisio。它是一种以患者为中心的数位化临床决策支援工具，可实现精准护理。
    • Biosense Webster 获得 FDA核准多种心房颤动消融产品，这些产品可用于无需透视的工作流程
    • Medtronic)用于房性心律不整治疗的 Aphera 标测和消融系统获得 CE 标誌核准
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Acesion Pharma ApS
  • Acutus Medical, Inc
  • Affera, Inc.
  • AFreeze GmbH
  • Atrian Medical Ltd.
  • AtriCure, Inc.
  • AuriGen Medical
  • BIOTRONIK SE & CO. KG
  • Boston Scientific Corporation
  • Cardiofocus, Inc.
  • CathRx Ltd
  • Cook Group Incorporated
  • F. Hoffmann-La Roche AG
  • GE HealthCare Technologies Inc.
  • Healium Medical
  • Japan Lifeline Co.
  • Johnson & Johnson Services, Inc.
  • Kardium Inc.
  • Koninklijke Philips NV
  • Medtronic PLC
  • OMEICOS Therapeutics GmbH
  • Osypka AG
  • SentiAR, Inc
  • Siemens Healthcare GmbH
  • Stryker Corporation
  • Terumo Corporation
  • Thryv Therapeutics Inc.
  • Toray Medical Co., Ltd.
  • Vanguard AG
  • Volta Medical
Product Code: MRR-436901065DB6

The Atrial Fibrillation Surgery Market was valued at USD 2.67 billion in 2023, expected to reach USD 2.90 billion in 2024, and is projected to grow at a CAGR of 9.00%, to USD 4.88 billion by 2030.

Atrial fibrillation (AF) surgery involves medical procedures designed to correct the irregular heartbeat associated with AF, often pursued when less invasive treatments fail. These surgeries, such as catheter ablation or the Maze procedure, are vital as AF can lead to serious complications like stroke or heart failure. The application extends to both symptomatic individuals and those at significant risk of complications, facilitated by hospitals and specialized cardiac centers. The global market for AF surgeries is primarily influenced by the rising prevalence of AF due to an aging population and increased awareness among patients and healthcare providers. Technological advancements in surgical procedures and equipment are opening new opportunities, with innovations like robotic-assisted surgeries and improved catheter designs holding potential to enhance outcomes and reduce recovery times. However, the high cost of these procedures and limited access in underdeveloped regions constrain market expansion. Regulatory challenges and the need for skilled professionals further complicate the landscape. To overcome these hurdles, strategic partnerships and collaborations for technology sharing and training could be key. In terms of research and innovation, areas such as AI-driven diagnostic and surgical planning tools, as well as improved monitoring systems post-surgery, present promising avenues for growth. Furthermore, enhancing insurance coverage and reimbursement frameworks may accelerate market development. The market is characterized by rapid technological advancements but also faces scrutiny from regulatory bodies, emphasizing the need for compliance and robust clinical validation. Companies must focus on value propositions that include cost-effective solutions and improved patient outcomes to capture market share. Overall, strategic investments in R&D, combined with efforts to broaden patient access and streamline procedural costs, are critical for sustained growth in the atrial fibrillation surgery market.

KEY MARKET STATISTICS
Base Year [2023] USD 2.67 billion
Estimated Year [2024] USD 2.90 billion
Forecast Year [2030] USD 4.88 billion
CAGR (%) 9.00%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Atrial Fibrillation Surgery Market

The Atrial Fibrillation Surgery Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in prevalence of atrial fibrillation in geriatric population
    • Development in preference of catheter ablation for cardiac arrhythmia treatment
    • Growing number of AF programs to enhance public awareness
  • Market Restraints
    • Regulatory issues associated with the devices
  • Market Opportunities
    • Increasing need for minimally invasive procedures, smaller cardiac incisions, and faster post-surgical recovery times
    • Technological advances for catheter ablation of atrial fibrillation
  • Market Challenges
    • Lack of skilled professionals and awareness among the people about the surgery

Porter's Five Forces: A Strategic Tool for Navigating the Atrial Fibrillation Surgery Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Atrial Fibrillation Surgery Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Atrial Fibrillation Surgery Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Atrial Fibrillation Surgery Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Atrial Fibrillation Surgery Market

A detailed market share analysis in the Atrial Fibrillation Surgery Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Atrial Fibrillation Surgery Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Atrial Fibrillation Surgery Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Atrial Fibrillation Surgery Market

A strategic analysis of the Atrial Fibrillation Surgery Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Atrial Fibrillation Surgery Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acesion Pharma ApS, Acutus Medical, Inc, Affera, Inc., AFreeze GmbH, Atrian Medical Ltd., AtriCure, Inc., AuriGen Medical, BIOTRONIK SE & CO. KG, Boston Scientific Corporation, Cardiofocus, Inc., CathRx Ltd, Cook Group Incorporated, F. Hoffmann-La Roche AG, GE HealthCare Technologies Inc., Healium Medical, Japan Lifeline Co., Johnson & Johnson Services, Inc., Kardium Inc., Koninklijke Philips N.V., Medtronic PLC, OMEICOS Therapeutics GmbH, Osypka AG, SentiAR, Inc, Siemens Healthcare GmbH, Stryker Corporation, Terumo Corporation, Thryv Therapeutics Inc., Toray Medical Co., Ltd., Vanguard AG, and Volta Medical.

Market Segmentation & Coverage

This research report categorizes the Atrial Fibrillation Surgery Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Cardiac Cryoablation Catheters and Cardiac Mapping System.
  • Based on Indication, market is studied across Atrial Fibrillation (AFib), Atrial Flutter, and Supraventricular Tachycardia (SVT).
  • Based on End-User, market is studied across Cardiology and Multi Specialities.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in prevalence of atrial fibrillation in geriatric population
      • 5.1.1.2. Development in preference of catheter ablation for cardiac arrhythmia treatment
      • 5.1.1.3. Growing number of AF programs to enhance public awareness
    • 5.1.2. Restraints
      • 5.1.2.1. Regulatory issues associated with the devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing need for minimally invasive procedures, smaller cardiac incisions, and faster post-surgical recovery times
      • 5.1.3.2. Technological advances for catheter ablation of atrial fibrillation
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled professionals and awareness among the people about the surgery
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Minimally invasive procedures are on demand with the rising utilization of catheter-based procedures
    • 5.2.2. Indication: Emergence of maze procedure as a preferred treatment for atrial fibrillation
    • 5.2.3. End-User: Accelerating cases of atrial fibrillation surgeries conducted in cardiology and multi-specialty centers
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Atrial Fibrillation Surgery Market, by Product

  • 6.1. Introduction
  • 6.2. Cardiac Cryoablation Catheters
  • 6.3. Cardiac Mapping System

7. Atrial Fibrillation Surgery Market, by Indication

  • 7.1. Introduction
  • 7.2. Atrial Fibrillation (AFib)
  • 7.3. Atrial Flutter
  • 7.4. Supraventricular Tachycardia (SVT)

8. Atrial Fibrillation Surgery Market, by End-User

  • 8.1. Introduction
  • 8.2. Cardiology
  • 8.3. Multi Specialities

9. Americas Atrial Fibrillation Surgery Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Atrial Fibrillation Surgery Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Atrial Fibrillation Surgery Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. GE HealthCare Launches CardioVisio for Atrial Fibrillation, a Digital, Patient-Centric Clinical Decision Support Tool to Enable Precision Care
    • 12.3.2. Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy
    • 12.3.3. Medtronic Receives CE Mark Approval For Affera Mapping And Ablation System To Treat Atrial Arrhythmias
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Acesion Pharma ApS
  • 3. Acutus Medical, Inc
  • 4. Affera, Inc.
  • 5. AFreeze GmbH
  • 6. Atrian Medical Ltd.
  • 7. AtriCure, Inc.
  • 8. AuriGen Medical
  • 9. BIOTRONIK SE & CO. KG
  • 10. Boston Scientific Corporation
  • 11. Cardiofocus, Inc.
  • 12. CathRx Ltd
  • 13. Cook Group Incorporated
  • 14. F. Hoffmann-La Roche AG
  • 15. GE HealthCare Technologies Inc.
  • 16. Healium Medical
  • 17. Japan Lifeline Co.
  • 18. Johnson & Johnson Services, Inc.
  • 19. Kardium Inc.
  • 20. Koninklijke Philips N.V.
  • 21. Medtronic PLC
  • 22. OMEICOS Therapeutics GmbH
  • 23. Osypka AG
  • 24. SentiAR, Inc
  • 25. Siemens Healthcare GmbH
  • 26. Stryker Corporation
  • 27. Terumo Corporation
  • 28. Thryv Therapeutics Inc.
  • 29. Toray Medical Co., Ltd.
  • 30. Vanguard AG
  • 31. Volta Medical

LIST OF FIGURES

  • FIGURE 1. ATRIAL FIBRILLATION SURGERY MARKET RESEARCH PROCESS
  • FIGURE 2. ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ATRIAL FIBRILLATION SURGERY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ATRIAL FIBRILLATION SURGERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ATRIAL FIBRILLATION SURGERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ATRIAL FIBRILLATION SURGERY MARKET DYNAMICS
  • TABLE 7. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY CARDIAC CRYOABLATION CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY CARDIAC MAPPING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ATRIAL FIBRILLATION (AFIB), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ATRIAL FLUTTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SUPRAVENTRICULAR TACHYCARDIA (SVT), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY MULTI SPECIALITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. ATRIAL FIBRILLATION SURGERY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. ATRIAL FIBRILLATION SURGERY MARKET, FPNV POSITIONING MATRIX, 2023